Skip to content
Homepage
Author:
Niowave Inc.
Posted Date:
June 16, 2026
Niowave, Inc. and Ratio Therapeutics Sign Supply Agreement for Actinium-225 to Advance Targeted Alpha Therapies
Niowave Inc.
June 16, 2026
Niowave Breaks Ground on New $75 Million Production Facility to Advance Targeted Cancer Therapies
Niowave Inc.
May 28, 2026
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies
Niowave Inc.
February 11, 2026
